1. Home
  2. FSCO vs PRCT Comparison

FSCO vs PRCT Comparison

Compare FSCO & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Credit Opportunities Corp.

FSCO

FS Credit Opportunities Corp.

HOLD

Current Price

$4.85

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$19.91

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSCO
PRCT
Founded
N/A
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
FSCO
PRCT
Price
$4.85
$19.91
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$35.44
AVG Volume (30 Days)
1.1M
1.8M
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.71
EPS
N/A
N/A
Revenue
N/A
$308,054,000.00
Revenue This Year
N/A
$31.34
Revenue Next Year
N/A
$24.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
37.22
52 Week Low
$4.28
$19.35
52 Week High
$7.65
$62.17

Technical Indicators

Market Signals
Indicator
FSCO
PRCT
Relative Strength Index (RSI) 45.01 34.77
Support Level $4.68 $19.64
Resistance Level $5.06 $29.27
Average True Range (ATR) 0.10 1.52
MACD 0.01 -0.13
Stochastic Oscillator 46.27 3.69

Price Performance

Historical Comparison
FSCO
PRCT

About FSCO FS Credit Opportunities Corp.

FS Credit Opportunities Corp is a closed-end management investment company. The Fund's primary investment objective is to generate an attractive total return consisting of a high level of current income and capital appreciation, with a secondary objective of capital preservation. It predominantly invests in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments. The credit instruments in which it invests are typically rated below investment grade by rating agencies or would be rated below investment grade if rated. To achieve its investment objectives, the fund focuses on strategies such as Opportunistic Credit, Special Situations, and Capital Structure Solutions.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: